Search company, investor...
Search

Predict your next investment

Private Equity
newone.com.cn/zszyzb

See what CB Insights has to offer

Investments

24

Portfolio Exits

4

About China Merchants Securities Capital

China Merchants Securities Capital, a wholly-owned subsidiary of China Merchants Securities, focuses on the management of private equity investment funds, management of industrial investment funds, and management of mezzanine funds. Currently, it has actively deployed businesses such as Pre-IPO, industrial merger and acquisition funds, growth funds, venture capital funds, mezzanine funds, and incubator funds.

China Merchants Securities Capital Headquarters Location

47th Floor, Block A, Jiangsu Building Yitian Road, Futian District

Shenzhen, Guangdong, 518026,

China

+86-755-25310403

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest China Merchants Securities Capital News

Chance Pharmaceuticals Secures USD 30M Series C

Oct 11, 2021

Chance Pharmaceuticals, a clinical-stage biotechnology company focusing on discovering, developing, and commercializing inhalation therapies for the world’s debilitating diseases, announced today the completion of a USD 30 million Series C financing, led by new investor Lapam Capital with participation from new investors including CMS Capital and HEDA BioVenture and existing investor Guozhong Capital.

China Merchants Securities Capital Investments

24 Investments

China Merchants Securities Capital has made 24 investments. Their latest investment was in Redtea Mobile as part of their Series B on July 7, 2022.

CBI Logo

China Merchants Securities Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/7/2022

Series B

Redtea Mobile

Yes

1

12/13/2021

Series B

Genefine

Yes

4

10/11/2021

Series C

Chance Pharmaceuticals

$30M

Yes

3

8/13/2021

Series A

Subscribe to see more

$99M

Subscribe to see more

10

5/24/2021

Series B

Subscribe to see more

Subscribe to see more

10

Date

7/7/2022

12/13/2021

10/11/2021

8/13/2021

5/24/2021

Round

Series B

Series B

Series C

Series A

Series B

Company

Redtea Mobile

Genefine

Chance Pharmaceuticals

Subscribe to see more

Subscribe to see more

Amount

$30M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

4

3

10

10

China Merchants Securities Capital Portfolio Exits

4 Portfolio Exits

China Merchants Securities Capital has 4 portfolio exits. Their latest portfolio exit was MicuRx Pharmaceuticals on August 05, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/5/2022

IPO

$99M

Public

1

2/10/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

5/22/2020

IPO - II

Subscribe to see more

$99M

Subscribe to see more

10

10/26/2018

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/5/2022

2/10/2021

5/22/2020

10/26/2018

Exit

IPO

IPO

IPO - II

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.